WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ... European Respiratory Journal 38 (3), 516-528, 2011 | 789 | 2011 |
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients SD Ahuja, D Ashkin, M Avendano, R Banerjee, M Bauer, JN Bayona, ... Public Library of Science 9 (8), e1001300, 2012 | 740 | 2012 |
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru C Mitnick, J Bayona, E Palacios, S Shin, J Furin, F Alcántara, E Sánchez, ... New England Journal of Medicine 348 (2), 119-128, 2003 | 726 | 2003 |
Comprehensive treatment of extensively drug-resistant tuberculosis CD Mitnick, SS Shin, KJ Seung, ML Rich, SS Atwood, JJ Furin, ... New England Journal of Medicine 359 (6), 563-574, 2008 | 530 | 2008 |
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 521 | 2018 |
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline P Nahid, SR Mase, GB Migliori, G Sotgiu, GH Bothamley, JL Brozek, ... American journal of respiratory and critical care medicine 200 (10), e93-e142, 2019 | 428 | 2019 |
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis KF Laserson, LE Thorpe, V Leimane, K Weyer, CD Mitnick, V Riekstina, ... The International Journal of Tuberculosis and Lung Disease 9 (6), 640-645, 2005 | 415 | 2005 |
Tuberculosis and chronic respiratory disease: a systematic review AL Byrne, BJ Marais, CD Mitnick, L Lecca, GB Marks International Journal of Infectious Diseases 32, 138-146, 2015 | 401 | 2015 |
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis KR Jacobson, DB Tierney, CY Jeon, CD Mitnick, MB Murray Clinical infectious diseases 51 (1), 6-14, 2010 | 349 | 2010 |
The dilemma of MDR-TB in the global era. P Farmer, J Bayona, M Becerra, J Furin, C Henry, H Hiatt, JY Kim, ... The international journal of tuberculosis and lung disease: the official …, 1998 | 301 | 1998 |
Multidrug-resistant tuberculosis management in resource-limited settings E Nathanson, C Lambregts-van Weezenbeek, ML Rich, R Gupta, ... Emerging infectious diseases 12 (9), 1389, 2006 | 255 | 2006 |
Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis J Furin J, D Mitnick C, S Shin S, J Bayona, C Becerra M, M Singler J, ... The International Journal of Tuberculosis and Lung Disease 5 (7), 648-655, 2001 | 247 | 2001 |
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment MF Franke, SC Appleton, J Bayona, F Arteaga, E Palacios, K Llaro, ... Clinical infectious diseases 46 (12), 1844-1851, 2008 | 209 | 2008 |
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects EV Kurbatova, A Taylor, VM Gammino, J Bayona, M Becerra, M Danilovitz, ... Tuberculosis 92 (5), 397-403, 2012 | 186 | 2012 |
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study MC Becerra, SC Appleton, MF Franke, K Chalco, F Arteaga, J Bayona, ... The Lancet 377 (9760), 147-152, 2011 | 179 | 2011 |
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two … EV Kurbatova, JP Cegielski, C Lienhardt, R Akksilp, J Bayona, ... The Lancet Respiratory medicine 3 (3), 201-209, 2015 | 171 | 2015 |
Tuberculosis pharmacotherapy: strategies to optimize patient care CD Mitnick, B McGee, CA Peloquin Expert opinion on pharmacotherapy 10 (3), 381-401, 2009 | 141 | 2009 |
World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential? KE Dooley, EA Obuku, N Durakovic, V Belitsky, C Mitnick, ... The Journal of infectious diseases 207 (9), 1352-1358, 2013 | 133 | 2013 |
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea SK Park, WC Lee, DH Lee, CD Mitnick, L Han, KJ Seung The International Journal of Tuberculosis and Lung Disease 8 (3), 361-368, 2004 | 127 | 2004 |
Community-based therapy for children with multidrug-resistant tuberculosis PC Drobac, JS Mukherjee, JK Joseph, C Mitnick, JJ Furin, H del Castillo, ... Pediatrics 117 (6), 2022-2029, 2006 | 125 | 2006 |